John M. Capek, EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES (ABT), sold 149,600 shares at $135.05 ($20.2M) on 2021-12-13, disclosed to the SEC on 2021-12-15.
Open-market sale of $20.2M ABT by EXECUTIVE VICE PRESIDENT. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ABT | SELL | 2019-06-21 | $4.0M | — | Filing → |
| ABT | SELL | 2018-07-26 | $4.2M | — | Filing → |
| ABT | SELL | 2017-02-22 | $4.2M | — | Filing → |